glp 1 for prediabetes GLP-1 Medications Infographic GLP-1 for Diabetes vs GLP-1

Our findings strongly suggest the answer is yes. Primes recent real-world study found 63% of high-potency GLP-1 (Wegovy or Zepbound) users who started treatment in Q1 2024 are still taking their medication after a year

Notably, the $500 range is also the amount manufacturers offer for self-pay obesity patients, raising important questions about whether these programs are truly benefiting those who need them most5,6

Quality Standards & Traceability

Each batch is tested for purity and potency to ensure you receive a consistent, high-quality product you can rely on

Primary care physicians often make decisions regarding the initiation of basal insulin in T2D, as they work closely with patients and are well placed to discuss and manage the transition to basal insulin therapy

Learn how to safely combine intermittent fasting with GLP-1 receptor agonists